Filing Details
- Accession Number:
- 0001104659-24-105580
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-10-02 21:54:44
- Reporting Period:
- 2024-10-01
- Accepted Time:
- 2024-10-02 21:54:44
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1041024 | Rockwell Medical Inc. | RMTI | Pharmaceutical Preparations (2834) | 383317208 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1599219 | Mark Strobeck | C/O Rockwell Medical, Inc. 30142 Wixom Road Wixom MI 48393 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2024-10-01 | 2,163 | $3.69 | 147,201 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2024 in multiple trades at prices ranging from $3.67 to $3.69. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.